Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients

Clinical trial NCT07583251 · RECRUITING

Trial details

NCT number: NCT07583251
Sponsor: Pravat Mandal
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Mild Cognitive Impairment (MCI)

Start date: 2026-08-04
Primary completion: 2027-01-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.